Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here:


We work continuously with a large collaboration network in the US and EU with over 30 pancreatic cancer experts worldwide.

United States: New York University Hospital, NY; Columbia University, NY; Mount Sinai Hospital, NY; Stanford Gastroenterology and Hepatology, CA; Yale University, CT; University of Chicago Medical Center, IL; Massachusetts General Hospital, MA; University of Massachusetts, MA; The Ohio State University, OH; Oregon Health & Science University, OR; University of Pennsylvania, PA; University of Pittsburgh Medical Center, PA; University of Utah, UT and Beth Israel Deaconess Medical Center, MA.

Canada: The Research Institute of the McGill University Health Centre, Montreal.

Denmark: Danish Centre for Strategic Research in Type 2 Diabetes (DD2).

Finland: Helsinki University Hospital

Germany: University Hospital Erlangen.

Sweden: Karolinska University Hospital; Sahlgrenska University Hospital; Umeå University Hospital, Linköping University Hospital, Lund University, Uppsala University, Lund University Diabetes Center (LUDC), Region Skåne and Region Uppsala.

Spain: University Hospital Ramon y Cajal, Madrid; University Hospital Santiago de Compostela and Catalan Institute of Oncology (ICO Hospitalet) – Bellvitge Biomedical Research Institute (IDIBELL), Barcelona.

United Kingdom: University College London, University College London Hospital and The University of Liverpool.